These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32847927)

  • 21. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Tudur Smith C
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001904. PubMed ID: 30353945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
    Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
    Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiepileptic drugs as prophylaxis for post-craniotomy seizures.
    Pulman J; Greenhalgh J; Marson AG
    Cochrane Database Syst Rev; 2013 Feb; (2):CD007286. PubMed ID: 23450575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.
    Glauser T; Ben-Menachem E; Bourgeois B; Cnaan A; Chadwick D; Guerreiro C; Kalviainen R; Mattson R; Perucca E; Tomson T
    Epilepsia; 2006 Jul; 47(7):1094-120. PubMed ID: 16886973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial.
    Bonnett L; Smith CT; Smith D; Williamson P; Chadwick D; Marson AG
    Lancet Neurol; 2012 Apr; 11(4):331-40. PubMed ID: 22377180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2015 Jul; (7):CD001904. PubMed ID: 26204241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001911. PubMed ID: 28240353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Hemming K; Marson AG
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005612. PubMed ID: 31287157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review.
    Connock M; Frew E; Evans BW; Bryan S; Cummins C; Fry-Smith A; Li Wan Po A; Sandercock J
    Health Technol Assess; 2006 Mar; 10(7):iii, ix-118. PubMed ID: 16545206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD001769. PubMed ID: 30091458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD001904. PubMed ID: 27976799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using routinely recorded data in the UK to assess outcomes in a randomised controlled trial: The Trials of Access.
    Powell GA; Bonnett LJ; Tudur-Smith C; Hughes DA; Williamson PR; Marson AG
    Trials; 2017 Aug; 18(1):389. PubMed ID: 28835254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
    Marson AG; Al-Kharusi AM; Alwaidh M; Appleton R; Baker GA; Chadwick DW; Cramp C; Cockerell OC; Cooper PN; Doughty J; Eaton B; Gamble C; Goulding PJ; Howell SJ; Hughes A; Jackson M; Jacoby A; Kellett M; Lawson GR; Leach JP; Nicolaides P; Roberts R; Shackley P; Shen J; Smith DF; Smith PE; Smith CT; Vanoli A; Williamson PR;
    Lancet; 2007 Mar; 369(9566):1016-26. PubMed ID: 17382828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zonisamide add-on therapy for focal epilepsy.
    Brigo F; Lattanzi S; Igwe SC; Behzadifar M; Bragazzi NL
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001416. PubMed ID: 30335200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2015 Aug; (8):CD001911. PubMed ID: 26275105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003615. PubMed ID: 30350354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zonisamide add-on therapy for focal epilepsy.
    Brigo F; Lattanzi S; Igwe SC; Behzadifar M; Bragazzi NL
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD001416. PubMed ID: 32715463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.
    Marson AG; Al-Kharusi AM; Alwaidh M; Appleton R; Baker GA; Chadwick DW; Cramp C; Cockerell OC; Cooper PN; Doughty J; Eaton B; Gamble C; Goulding PJ; Howell SJ; Hughes A; Jackson M; Jacoby A; Kellett M; Lawson GR; Leach JP; Nicolaides P; Roberts R; Shackley P; Shen J; Smith DF; Smith PE; Smith CT; Vanoli A; Williamson PR;
    Lancet; 2007 Mar; 369(9566):1000-15. PubMed ID: 17382827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxcarbazepine versus phenytoin monotherapy for epilepsy.
    Muller M; Marson AG; Williamson PR
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003615. PubMed ID: 16625587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.